More results...
Inroduction ChatGPT or more generally speaking OpenAI is an incredible tool. It is a spectacular instrument helping people in many different fields, it helps people to summarize text, to produce poem, to build images and music, to answer to difficult questions and to automatize complex processes. So I decided to dedicate an entire blog-post to […]
Climate change didn’t make the dry spell more likely, researchers found, though extreme heat probably made it hurt more.
A robot lowered through the ice reveals how the Thwaites shelf is melting, which will help forecast its effect on global sea level.
Keeper Security, the provider of cloud-based zero-trust and zero-knowledge cybersecurity software protecting passwords, secrets and connections, has released findings from its Privileged Access Management Survey: User Insights on Cost & Complexity. The report explores global insights from IT and security executives, revealing an overwhelming industry desire for Privileged Access Management (PAM) solutions that are easier to […]
The post Traditional PAM solutions aren’t working, Keeper Security study finds appeared first on IT Security Guru.
We decided to check what ChatGPT already knows about threat research and whether it can help with identifying simple adversary tools and classic indicators of compromise, such as well-known malicious hashes and domains.
Three vulnerabilities found in a variety of Korenix JetWave industrial access points and LTE cellular gateways may allow attackers to either disrupt their operation or to use them as a foothold for further attacks, CyberDanube researchers have found. &…
A wave of teenagers who developed tics during the pandemic has receded, illustrating the powerful influence of stress on the body and the resilience of adolescents.
Kizzmekia Corbett helped lead a team of scientists contributing to one of the most stunning achievements in the history of immunizations: a highly effective, easily manufactured vaccine against Covid-19.
A new drug quashes all coronavirus variants. But regulatory hurdles and a lack of funding make it unlikely to reach the U.S. market anytime soon.
Oxford and Cambridge universities, once given more than £130m a year in total by European research programmes, are now getting £1m annually between themOne of the UK’s most prestigious universities has seen its funding from a large European research pr…